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Oligodendrocytes derive from progenitors (OPCs)
through the interplay of epigenomic and transcrip-
tional events. By integrating high-resolution meth-
ylomics, RNA-sequencing, and multiple transgenic
lines, this study defines the role of DNMT1 in devel-
opmental myelination. We detected hypermethyla-
tion of genes related to cell cycle and neurogenesis
during differentiation of OPCs, yet genetic ablation
of Dnmt1 resulted in inefficient OPC expansion
and severe hypomyelination associated with ataxia
and tremors in mice. This phenotype was not
caused by lineage switch or massive apoptosis
but was characterized by a profound defect of dif-
ferentiation associated with changes in exon-skip-
ping and intron-retention splicing events and by
the activation of an endoplasmic reticulum stress
response. Therefore, loss of Dnmt1 in OPCs is not
sufficient to induce a lineage switch but acts as an
important determinant of the coordination between
RNA splicing and protein synthesis necessary for
myelin formation.
INTRODUCTION
Brain development requires the integration of cell-lineage se-
lection and cell number regulation. This is achieved by coordi-
nating cell proliferation with lineage identity. DNA methylation
is a well-recognized epigenetic modification that is carefully748 Cell Reports 15, 748–760, April 26, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://regulated during cell division and guarantees faithful trans-
mission of information to the daughter cells. This enzymatic
activity is modulated by three proteins: DNMT1 (maintenance
DNA methyltransferase, commonly associated with faithful
transmission of genomic information from mother to daughter
cells during cell division), DNMT3A, and DNMT3B (de novo
methyltransferases methylating specific cytosines during
development). The activity of these enzymes in the brain is
higher than in any other adult tissue (Ono et al., 1993; Tawa
et al., 1990), highlighting the importance of DNMTs in neural
development (Lister et al., 2013; Smith and Meissner, 2013).
This study addresses the role of DNA methylation in develop-
mental myelination.
Genetic loss of Dnmt1 is lethal in mammals (Li et al., 1992)
and zebrafish (Jacob et al., 2015), because rapidly proliferating
cells need to retain a stable epigenetic signature and are elim-
inated by apoptosis if compromised (Jackson-Grusby et al.,
2001; Unterberger et al., 2006). An example is the apoptotic
elimination of neural stem cells and mitotic neuroblasts lacking
Dnmt1 (Fan et al., 2001; Hutnick et al., 2009; Milutinovic et al.,
2003). In contrast, inhibiting DNA methylation in astrocytes or
Schwann cells is associated with precocious onset of differen-
tiation, due to the unmasking of critical transcriptional regula-
tory sites in differentiation genes (Fan et al., 2005; Takizawa
et al., 2001 ;Varela-Rey et al., 2014). In this study, we show
that ablation of Dnmt1 in the oligodendrocyte (OL) lineage
does not result in apoptosis or precocious myelination but
causes the growth arrest of OL progenitors (OPCs) and a
severely disrupted pattern of alternative splicing with the acti-
vation of an endoplasmic reticulum (ER) stress response, which
precludes differentiation and results in severe and clinically
symptomatic hypomyelination.creativecommons.org/licenses/by-nc-nd/4.0/).
RESULTS
Dynamic DNA Methylation and DNA Methyltransferase
Expression during OL Differentiation
DNA methylation in proliferating progenitors has been shown to
prevent untimely differentiation and to guarantee faithful trans-
mission of genomic information from mother to daughter cells
during replication (Fan et al., 2005; Probst et al., 2009; Sen
et al., 2010; Varela-Rey et al., 2014). To begin characterizing
the role of DNA methylation in OL-lineage cells, we quantified
5-methylcytosine (5-mC) in developing white matter tracts dur-
ing embryonic and postnatal development. Quantification of
the percentage of OLIG2+ OPCs expressing 5-mC (Figure 1A)
revealed a greater proportion of highly methylated cells at late
developmental time points (Figure 1B). A similar pattern was de-
tected in cultured OPCs during differentiation into OLs (Figures
1C and 1D). To further understand the role of DNA methylation
in OPCs, we also evaluated the transcript (Figures 1E and 1F)
and protein (Figure 1G) levels of the maintenance DNA methyl-
transferase Dnmt1 and the de novo methyltransferases Dnmt3a
and Dnmt3b at two stages of development. While Dnmt1 levels
decreased with differentiation, Dnmt3a levels did not signifi-
cantly change, and Dnmt3b levels were undetectable at either
stage (data not shown).
To generate a genome-widemap of the DNAmethylation land-
scape during the transition from OPC to OL, we used fluores-
cence-activated cell sorting (FACS) of the brains from transgenic
mice expressing GFP driven by OL-lineage-specific promoters
at postnatal day (P)2 (Pdgfra-GFP) and P18 (Plp1-GFP) (Fig-
ure 2A). We previously characterized the Pdgfra-GFP sorted
OPC as expressing progenitor markers (e.g., Cspg4 and Pdgfra)
and not expressing myelin genes (e.g., Mog and Mag), while
Plp1-GFP sorted OLs were characterized by the expression of
differentiation genes and the absence of progenitor markers
(Moyon et al., 2015). DNA methylation mapping was performed
by enhanced reduced representation bisulfite sequencing
(ERRBS), which combined restriction enzyme digestion (i.e.,
MspI) of genomic DNA with bisulfite sequencing and provided
single-base resolution and highly quantitative data on the
methylation state of cytosines throughout the genome. The
mean coverage was 1.47 million individual CpGs in the mouse
genome (Table S1), with themajority detected at gene promoters
(Figure S1C). Among those, we identified 62,807 differentially
methylated CpGs as OPCs differentiated (q value <0.01) with
29,707 hypomethylated and 33,100 hypermethylated CpGs. Re-
gions containing at least two CpGs with a minimum difference of
10% between the two stages of differentiation were classified as
differentially methylated regions (DMRs). This revealed the clus-
tering of CpGs into 7,386 DMRs characterizing the differentiation
of OPC, with 2,385 hypermethylated regions (with an average
methylation difference of 22.2% ± 8.5%) (Figure S1B). Biological
replicates confirmed the reproducibility of the methylation state
(Pearson’s r > 0.9), while comparisons of DMRs in samples ob-
tained at the two developmental time points displayed great
disparity (Figure S1A), further supporting the large shift in the
DNAmethylome during differentiation. To determine the relation-
ship between DNA methylation and transcription, we performed
RNA sequencing (RNA-seq) on the same FACS-isolated popula-tions (Figure 2; Table S2). Separate clustering of the samples
isolated at distinct time points and differential expression
of stage-specific markers (Pdgfra: fold change, 8.2; q value =
5.5 3 10220; Cspg4: fold change, 7.0; q value = 4.5 3
10169; Plp1: fold change, 2.3; q value = 6.4 3 103; Mog: fold
change, 4.9; q value = 2.09 3 1034; Mag: fold change, 2.4;
q value = 2.6 3 1026) between the two populations confirmed
the selectivity of our cell sorting (Figure S2A). The analysis re-
vealed 3,204 upregulated (average fold change = 3.6 ± 1.8)
and 3,547 downregulated transcripts (average fold change =
5.6 ± 2.4) during differentiation. Upregulated genes included
gene ontology (GO) categories related to lipid metabolism
and axon ensheathment, while downregulated categories
included cell cycle, cell migration, and neuronal differentiation
(Figures S2B and S2C). The overwhelming overlap (p < 10244)
of our dataset and the published in vitro RNA-seq study (Zhang
et al., 2014) further strengthened the validity of our analysis
(Figure S2D).
To characterize the transcriptional consequences of genome-
wide distribution of DNA methylation, we overlapped the differ-
ential transcript expression with DNA methylation differences
at promoters and represented the analysis as quadrant plot,
based on statistical power (Figure 2B). The most statistically sig-
nificant differences (based on number of events and difference at
the two developmental stages) were identified in two quadrants
(I and IV). The highest significance was detected in quadrant IV
(p = 8.1 3 1019), which defined hypermethylated genes with
decreased expression during differentiation and included genes
related to neuronal lineage (e.g., Pax6, Plxnb2, Camk1, and
Ephb2) and proliferation (e.g., Cdc6 and Meis2) (Figures 2D
and 2F). Quadrant I was also significant (p = 2.5 3 107) and
included hypomethylated genes with increased expression dur-
ing differentiation, such as lipid enzymes, myelin components
(e.g., Mog and Mag), and enzymes enriched in the myelin
compartment such as carbonic anhydrase II (Car2), as well as
molecules associated with the differentiated state such as the
G-protein-coupled receptor 37 (Gpr37) (Figures 2C and 2E).
The other two quadrants (hypomethylated genes with decreased
expression or hypermethylated genes with increased expression
during differentiation) did not reach statistical significance and,
therefore, were not pursued any further. Taken together, these
data highlight the relevance of DNA methylation in OPCs for
silencing genes related to cell proliferation and neuronal lineage.
Ablation of Dnmt1, but Not Dnmt3a, in OPCs during
Development Impairs Differentiation and Results in
Widespread Myelination Deficits
To define the functional role of DNAmethylation in the OL lineage
in vivo, we crossed the Dnmt1fl/fl and Dnmt3afl/fl lines with Olig1-
cre to target embryonic progenitors and with the Cnp-cre line to
target later stages of OL development. Littermates lacking cre
expression were used as controls. The cell specificity of gene
ablation was confirmed by double immunofluorescence, using
antibodies specific forDNMT1 (Figure 3A) orDNMT3A (Figure 3B)
and those specific for cell markers. Lack of DNMT1 or DNMT3A
immunoreactivity in OLIG2+ cells, but not in glial fibrillary acidic
protein (GFAP)-positive (GFAP+) or neuronal-marker (NeuN)-
positive (NeuN+) cells, indicated lineage-selective ablationCell Reports 15, 748–760, April 26, 2016 749
Figure 1. Increased Levels of DNA Methylation and Dynamic Expression of DNA Methyltransferases during OL Development
(A) Immunostaining of DNAmethylation using 5-mC antibody (green) and OLIG2 (red) in spinal cord sections revealed the presence of cells with low, medium, and
high 5-mC levels of staining intensity.
(B) Quantification of 5-mC immunoreactive OLIG2+ cells in mouse developing spinal cord white matter at E17–E18 (E17-18), P1, and P21.
(C) Left: protocol for culturing proliferating OPCs (PDGF + FGF [fibroblast growth factor]) and inducing differentiation into OLs (T3). Right: dot-blot analysis for
5-mC and dsDNA as control.
(D) Quantification of 5-mC levels relative to total dsDNA in OPCs and OLs.
(E) Scheme of FACS of P2 PDGFRa-GFP OPCs and P18 PLP-GFP OLs. FITC, fluorescein isothiocyanate.
(F) Dnmt1 and Dnmt3a mRNA levels in sorted OPCs and OLs relative to OPCs.
(G) Representative image of nuclear DNMT1 and DNMT3A (green) immunostaining in OLIG2+ OPCs and CC1+ OLs (red).
Scale bars, 10 mm. Data represent mean ± SEM. *p < 0.05 (ANOVA and Student’s t test).(Figures 3A and 3B). Both Olig1cre/+;Dnmt1fl/fl and Olig1cre/+;
Dnmt3afl/fl mice appeared normal at birth; however, by P9, only
the Olig1cre/+;Dnmt1fl/fl mice developed tremors and ataxia
(Movie S1), eventually leading to decreased survival by the
third postnatal week (Figure 3C). Both Olig1cre/+;Dnmt3afl/fl and750 Cell Reports 15, 748–760, April 26, 2016Cnpcre/+;Dnmt1fl/fl mice showed no obvious phenotype (Fig-
ure 3C). Consistent with these observations, myelin basic protein
(MBP) staining of spinal cord sections at P16 revealed a dramatic
hypomyelination only in theOlig1cre/+;Dnmt1fl/flmice (Figure 3D).
Gross examination of Olig1cre/+;Dnmt1fl/fl mice at P14 revealed
Figure 2. Negative Correlation between
DNA Methylation and Transcript Levels in
Oligodendroglial-Lineage Cells
(A) Scheme of experimental approach used for
RNA-seq and high-resolution methylomics.
(B) Quadrant plot of DMRs at gene promoters
and differentially expressed genes (OLS versus
OPCS). The x axis refers to DNA methylation
differences during differentiation. The y axis in-
dicates log2 fold change of transcript levels.
Horizontal (10% difference) and vertical (2-fold
change) dashed lines identify four quadrants:
(I) hypomethylated and upregulated genes (red
circle), (II) hypomethylated and downregulated
(black square), (III) hypermethylated and upregu-
lated (black diamond), and (IV) hypermethylated
and downregulated (green triangle). Colored
genes in quadrants I and IV are characterized by
statistically significant differences in methylation
and transcript levels (p value indicated in each
quadrant).
(C and D) Top GO categories for upregulated and
hypomethylated genes (red; C) and for down-
regulated and hypermethylated (green; D) genes.
(E and F) The bar graphs represent statistically
significant DNA methylation levels of individual
CpGs (blue boxes over gene structures) in OPCs
(white bars) and OLs (gray bars). Note the signifi-
cantly decreased methylation of CpGs in myelin
genes (E) and increased methylation in cell cycle
and neuronal genes (F) during differentiation.
Data indicate mean ± SEM. *p < 0.05; **p < 0.01;
***p < 0.005 (false discovery rate).
See also Figures S1 and S2.only minor differences in body size (Figure 3E) but clear signs of
hypomyelination of the spinal cord (see Figure 3F, translucent
spinal cord) and brain stem (Figure 3G), which were confirmed
by electron microscopy (Figures 3H and S3).
The Hypomyelinated Phenotype Detected in Dnmt1
Mutants Is Not Attributable to Fate-Lineage Switch
Given the early activity of Olig1-cre at the pMN domain (Zhou
and Anderson, 2002) and based on the detection of increased
methylation and silencing of neuronal lineage-related genes dur-
ing OPC differentiation, it was important to determine whether
the defective myelination phenotype detected in Olig1cre/+;
Dnmt1fl/fl mice could be attributed to impaired specification. To
address this question, we used two approaches. First, we pro-
cessed spinal cord sections from mutants and control siblings
at embryonic day (E)12.5 for immunohistochemistry using anti-
bodies specific for motor neurons (i.e., MNX1), as well as ventralCe(i.e., NKX2.2) and dorsal (i.e., PAX6)
markers. Quantification of immunoreac-
tive cells revealed no differences in the
number of OLIG2+ at the pMN domain
or of MNX1+ at the ventrolateral motor
neuron domain (Figures 4A and 4B). The
distribution and number of NKX2.2+
(Figure 4C) and PAX6+ cells (Figure 4D)
were similar inmice of the two genotypes,and the boundaries with theOLIG2+ domain were preserved.We
then conducted a fate-mapping analysis crossing the ROSA26-
loxSTOP-lox-TdTomato reporter line with theOlig1cre/+;Dnmt1fl/fl
or Olig1cre/+;Dnmt1+/+ mice and stained spinal cord sections at
P14 with neuronal (NeuN) or astrocytic (GFAP) markers (Figures
4E and 4F). Only very few cells were identified by the reporter
expression and staining for NeuN or GFAP, both in controls and
mutants (NeuN controls = 2.5% ± 0.3%, mutants = 3.2% ±
1.0%; GFAP controls = 3.0% ± 0.4%, mutants = 3.7% ± 0.6%),
suggesting that only very few OPCs differentiated in neurons or
astrocytes in the absence of Dnmt1.
Dnmt1-Dependent Hypomyelination as a Result of
Defective Differentiation
To define the potential cause of the hypomyelinating phenotype,
we conducted a quantitative immunohistochemical study of the
developing spinal cord from E16.5 to P16 using antibodiesll Reports 15, 748–760, April 26, 2016 751
Figure 3. Conditional Ablation of DNA Methyltransferases in OL-Lineage Cells Results in Widespread Hypomyelination in the CNS of
Olig1cre/+;Dnmt1fl/fl Mice
(A and B) Double immunostaining of P16 spinal cord with antibodies for DNMT1 (red; A) or DNMT3A (red; B) and the cell-specific markers (green): OLIG2 for OLs,
GFAP for astrocytes, and NeuN for neurons. Note the absence of DNMT1 (A) or DNMT3A (B) in the OL lineage. Scale bar, 10 mm.
(legend continued on next page)
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specific for OLIG2 and platelet-derived growth factor receptor a
(PDGFRa) to label OPCs, CC1 to label newly generated OLs, and
MBP to label myelinating cells. While a similar number of progen-
itorswas detected in the embryonic spinal cord, a 27% reduction
in the number of OPCs was detected in the mutant spinal cords
(Figure 5A) and brains (Figure S4A), starting from P2. A greater
reduction was observed for newly generated OLs (Figures 5B
and S4B), and an even more dramatic impairment was detected
when quantifying myelinating MBP+ cells (Figures 5C and S4C),
which represent a later stage of differentiation. The cell-autono-
mous nature of this defect was further validated in vitro, which
revealed defective differentiation of mutant OPCs compared to
controls (Figure 5D). Together, these data support the critical
importance of DNMT1 in the OL lineage to coordinate the late
stages of differentiation into myelin-forming cells.
To begin understanding the mechanisms underlying the very
modest decrease in progenitor numbers and the almost com-
plete absence of myelin detected by electron microscopy, we
processed spinal cord sections from controls and mutants at
multiple developmental time points for TUNEL (data not shown)
or for the presence of active cleaved caspase-3. An accurate
assessment of apoptotic nuclei is difficult in vivo, due to rapid
clearance, and despite the detection toward modestly increased
apoptosis at P9, themeasurable differences did not reach statis-
tical significance (Figure 6A). An alternative explanation for the
reduced OPC number was impaired proliferation. Co-labeling
of OPCs with antibodies specific for OLIG2 or PDGFRa and
markers of proliferation (i.e., Ki67) or of mitotic activity (i.e., phos-
phorylated histone H3) (Figures 6B and 6D) identified a clear
proliferation defect in mutants. This result was cell intrinsic, as
it was also detected in cultured OPCs (Figures 6C and 6E). We
concluded that the lower number of OPCs in the developing
spinal cord of mutant mice compared to that of age-matched
controls could, at least in part, be attributed to defective expan-
sion of the progenitor pool in the absence of Dnmt1. Since this
phenotype was associated with the detection of concurrent
hypomethylation and increased transcripts for genesmodulating
mitosis (e.g.,Meis2 and Cdc6), together with those inhibiting the
cell cycle (e.g., Cdkn1a), and with the downregulation of positive
regulators of proliferation (e.g., Pdgfra, Rbl2, and Mcm7) (Fig-
ures 6F and 6G), we reasoned that OPCs might have activated
strategies to counteract the consequences ofDnmt1 ablation af-
ter escaping apoptosis. The transcriptional changes leading to
opposing effects on proliferation suggested the potential activa-
tion of a genotoxic response, possibly resulting in growth arrest.
This was validated by the detection of phosphorylated H2AX
immunoreactivity, a histone mark demarcating regions of chro-
matin with double-stranded DNA (dsDNA) breaks (Unterberger
et al., 2006), both in vivo (Figure 6H) and in vitro (Figure 6I).(C) Kaplan–Meier survival curves forOlig1+/+;Dnmt1fl/fl andOlig1cre/+;Dnmt1fl/flmic
Cnpcre/+;Dnmt1fl/fl mice.
(D) Representative P16 spinal cord sections of Olig1+/+;Dnmt1fl/fl and Olig1
Cnp+/+;Dnmt1fl/fl and Cnpcre/+;Dnmt1fl/fl mice stained for MBP (green) and OLIG2
(E–G) Gross analysis of P14 Olig1cre/+;Dnmt1fl/fl mutants revealed minimal differ
matter in spinal cord (F) and brain stem (circle in G). Scale bars, 600 mm (E) and
(H) Electronmicrograph analysis of P16 spinal cord and corpus callosum sections
See also Figure S3 and Movie S1.Ablation of Dnmt1 in OPCs Activates an ER Stress
Response at the Late Stage of Differentiation due to
Massive Alteration of Alternative Splicing Events
To better define the dramatic hypomyelinating phenotype of
mutant mice, we conducted an unbiased transcriptomic analysis
of OPCs sorted from P5 Olig1+/+;Dnmt1fl/fl;Pdgfra-GFP and
Olig1cre/+;Dnmt1fl/fl;Pdgfra-GFP using RNA-seq (Figure S5A;
Table S3). Loss of Dnmt1 resulted in 994 downregulated and
566 upregulated genes in mutant cells, compared to controls
(Tables S4 and S5). Downregulated genes included myelin
genes, OL-specific factors, and lipid metabolism enzymes (Fig-
ure S3B), which were further validated by qPCR (Figure S3D).
Upregulated gene categories included cell division and response
to DNA stress (Figures 6G and S3C). Consistent with the detec-
tion of normal lineage specification, we did not detect any upre-
gulation of neuronally enriched gene categories. Because OL
differentiation is characterized by alternatively spliced events
(Kevelam et al., 2015; Nave et al., 1987), we interrogated our
RNA-seq dataset in control and mutant cells (Figure 7A). It has
been suggested that DNA methylation in specific genomic re-
gions is critical for exon skipping and intron retention splicing
events (Gelfman et al., 2013; Yearim et al., 2015). Consistent
with these data, we detected severe impairment of exon skip-
ping and intron retention splicing in mutant OPC (Olig1cre/+;
Dnmt1fl/fl;Pdgfra-GFP) compared to wild-type (Figure 7B). These
events occurred in GO categories identified as: myelination, lipid
metabolism and cell cycle (Figure 7C). An example of splicing
defects associated with defective DNA methylation is shown
for the gene Mcm7, a ubiquitously expressed cell cycle gene
characterized by intron retention (Figure 7D). Hypermethylated
CpGs in wild-type OPC within the spliced regions were associ-
ated with intron splicing while hypomethylated CpGs in mutant
cells were associated with intron-retention (Figure 7E). Together,
these data provided molecular validation of the relationship be-
tween aberrant DNA methylation and alternatively spliced
defect, as suggested by the RNA-seq analysis.
It is likely that aberrant splicing might change protein confor-
mation (Kevelam et al., 2015; Yura et al., 2006) and lead to the
potential accumulation of incorrectly folded proteins inducing
ER stress. Consistent with this possibility, we observed dilated
ERs in mutant OLs, with characteristic and unique electron-
dense inclusions (Figure 7F), suggestive of protein accumula-
tions and activation of ER stress response. This interpretation
was further supported by the detection of specific downstream
targets of ER response pathways in mutant mice, including Bip
(downstream of ATF6),Chop (downstreamof PERK), and spliced
Xbp1 (downstream of the IRE1 pathway) (Figure 7G). The ER
stress response was only detected in Olig1cre/+;Dnmt1fl/fl mice,
as ablation of Dnmt1 at later stages in Cnpcre/+;Dnmt1fl/fl micee,Olig1+/+;Dnmt3afl/fl andOlig1cre/+;Dnmt3afl/flmice, andCnp+/+;Dnmt1fl/fl and
cre/+;Dnmt1fl/fl mice, Olig1+/+;Dnmt3afl/fl and Olig1cre/+;Dnmt3afl/fl mice, and
(red). Scale bars, 100 mm.
ences in body size compared to controls (E) and complete absence of white
200 mm (F and G).
reveal severe hypomyelination in theOlig1cre/+;Dnmt1fl/flmice. Scale bar, 1 mm.
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Figure 4. Normal Cell Specification in Olig1cre/+;Dnmt1fl/fl Spinal Cord
(A) Representative confocal image of E12.5 spinal cord sections fromOlig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl mice, stained for OLIG2 (red) and MNX1 (green),
and quantification of MNX1+ cells in control (white bars) and mutants (gray bars).
(B) Quantification of OLIG2+ cells in controls and mutants.
(C) Representative E12.5 spinal cord sections stained for OLIG2 (red) and NKX2.2 (green) and relative quantification in controls and mutants.
(D) Representative E12.5 spinal cord sections stained for OLIG2 (red) and PAX6 (green) and relative quantification in controls and mutants.
(E and F) Representative P14 spinal cord sections of RosaTdTomato;Olig1cre/+;Dnmt1+/+ and RosaTdTomato;Olig1cre/+;Dnmt1fl/fl mice, stained for NeuN (E) or GFAP
(F), and percentage of NeuN+/TdTomato+ (E) or GFAP+/TdTomato+ (F) cells among the TdTomato+ cells.
Scale bars, 150 mm. Data indicate mean ± SEM. *p < 0.05 (ANOVA and Student’s t test).did not induce any change (Figure 7H). These results suggested
that Dnmt1 ablation in OPCs resulted in inappropriate protein
folding, likely as a result of the dramatic changes in alternative
splicing events detected in mutants.
Overall, this study supports a role for DNA methylation in OL
differentiation that goes beyond the repression of progenitor
stage genes and includes the regulation of alternative splicing
events at later stages of differentiation, which are critical for
the attainment of the myelinating phenotype.
DISCUSSION
OPCs are the last cells to differentiate in the developing CNS,
and their maturation is characterized by the silencing of alterna-
tive lineages and genome-wide deposition of repressive histone
K9 and K27 methylation marks (Liu et al., 2015; Sher et al., 2008,
2012). Our genome-wide analysis of differentially methylated
genes during the differentiation of OPCs into OLs directly sorted754 Cell Reports 15, 748–760, April 26, 2016from developing brains revealed hypermethylation at the pro-
moter of OPC-specific genes in response to mitogens (such as
Pdgfra), as well as regulators of DNA replication (such as
Cdc6), and neuronal-lineage genes (such as Pax6). This sug-
gested that DNA methylation contributes to the transition of
OPCs to OLs by regulating cell-cycle exit and, possibly, lineage
choice decisions. The concept of fine-tuning of the DNA methyl-
ome during mammalian brain development was previously
suggested (Kessler et al., 2016; Lister et al., 2013), and we had
predicted two potential outcomes to the ablation of Dnmts in
OPCs: increased OPC proliferation and potential lineage-choice
switch. In neural stem cells, Dnmt1 ablation led to decreased
survival and astroglial differentiation (Fan et al., 2001); in astro-
cytes, it led to precocious differentiation (Fan et al., 2005; He
et al., 2005).
Interestingly, none of the predicted outcomes was observed in
mice withDnmt1 ablation in theOL lineage. Despite the hypome-
thylation of myelin genes, OPCs did not undergo precocious
Figure 5. Impaired OPC Cell Differentiation in Olig1cre/+;Dnmt1fl/fl Mice
(A) Representative P16 spinal cord (SC) sections of Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl mice, stained for OLIG2 (red) and PDGFRa (green), and quanti-
fication of PDGFRa+/OLIG2+ cells at indicated time points. Scale bar, 40 mm.
(B) Representative image of P16 spinal cord sections stained for OLIG2 (red) and CC1 (green) and relative quantification. Scale bar, 100 mm.
(C) Representative image of P16 spinal cord sections of mutants and controls, stained for OLIG2 (red) and MBP (green) and relative quantification, showing
extensive hypo-myelination. Scale bar, 100 mm.
(D) Schematic of immunopanning from Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl P6 cortex to assess in vitro differentiation, and quantification of the number of
CC1+/OLIG2+ and MBP+/OLIG2+ cells in T3 medium.
Data indicate mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.005 (ANOVA).
See also Figure S4.differentiation. Given the relationship between cell-cycle exit and
differentiation (Magri et al., 2014), a potential explanation for the
mouse phenotype was the possible retention of OPCs in a prolif-
erative state, which was suggested by the hypomethylation of
genes regulating DNA replication (e.g., Meis2 and Cdc6). How-
ever, mutant OPCs exited from the cell cycle and inefficientlydifferentiated, despite the removal of the ‘‘methylation brake’’
on the promoter of myelin genes. Reduced OPC proliferation
was associated with the detection of phoshorylated histone
H2AX, a measure of genotoxic stress (Albino et al., 2009;
Lawless et al., 2010). This was consistent with the idea that
DNMT1 plays a critical role in the fidelity of transmission ofCell Reports 15, 748–760, April 26, 2016 755
Figure 6. Proliferation Defect and Genotoxic Damage in Olig1cre/+;Dnmt1fl/fl OPCs
(A) Representative P9 spinal cord sections of Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl mice, stained for OLIG2 (red) and cleaved-CASPASE3 (green), and
quantification of cCASPASE3+ cells in the spinal cord at the indicated time points.
(B) Representative P9 spinal cord sections of Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl mice, stained for OLIG2 (red) and Ki67 (green), and quantification of
Ki67+/OLIG2+ cells at P2 and P9.
(C) RepresentativeOlig1+/+;Dnmt1fl/fl andOlig1cre/+;Dnmt1fl/fl immunopanned OPCs, stained for PDGFRa (red) and Ki67 (green), and quantification of the number
of Ki67+/PDGFRa+ cells in PDGF + FGF medium.
(D) Representative P9 spinal cord sections ofOlig1+/+;Dnmt1fl/fl andOlig1cre/+;Dnmt1fl/flmice, stained for OLIG2 (red) and phospho-H3 (green), and quantification
of phospho-H3+/OLIG2+ cells at P9.
(legend continued on next page)
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epigenetic information from mother to daughter cells during cell
division (Fan et al., 2001; Probst et al., 2009; Sen et al., 2010).
In its absence, specific ‘‘sensors’’ induce dsDNA breaks and
activate specific kinases that, in turn, phosphorylate the nucleo-
somal histones and mark these regions as ‘‘damaged’’ (Altaf
et al., 2007; Me´ndez-Acun˜a et al., 2010; Rossetto et al., 2012).
This initiates a response resulting in growth arrest or apoptosis,
in an attempt to contain the number of cells with aberrant infor-
mation (Milutinovic et al., 2003; Unterberger et al., 2006). In
contrast to other cell types (Fan et al., 2001; Jacob et al.,
2015), OPCs lacking Dnmt1 did not display massive apoptosis,
and we reasoned that this was likely due to the fact that OPCs
are the last cells to differentiate at the tail end of development,
when all the other organs and systems are already in place,
and altered DNA methylation in these cells may not represent
an immediate threat to the overall health of the organism.
After exiting from the cell cycle, OPCs only inefficiently differ-
entiated into OLs and they were unable to generate large
amounts of myelin components, thereby resulting in a severely
hypomyelinated phenotype, which could not be explained sim-
ply in terms of cell number reduction. We also did not detect
increased expression of neuronal or astrocytic genes, indicative
of a potential lineage switch. This was consistent with the results
of fate-mapping experiments and highlighted the reliance of
lineage choices on multiple modalities of repression requiring
the concerted cooperation of DNA methylation and repressive
histone methylation marks occurring during OL differentiation
(Liu et al., 2015).
At the ultrastructural level, the preservation of axonal diameter
in mutants, despite the absence of myelin suggested, at least in
part, the preservation of signaling betweenOLs and axons. How-
ever, the detection of enlarged ER cisternae and electron-dense
inclusion bodies in mutant OLs was reminiscent of proteina-
ceous aggregates reported in other cell types (Ronzoni et al.,
2010; Valetti et al., 1991) and suggested the activation of an
ER stress response. A detailed molecular analysis of the three
ER response pathways identified the sequential activation of
the ATF6 and PERK pathways prior to the engagement of
the IRE1 response (Hetz et al., 2013; Oslowski and Urano,
2011), validating the results of the ultrastructural data. A poten-
tial explanation for the activation of the ER stress response in
oligodendroglial cells lacking Dnmt1 was suggested by RNA
sequencing analysis that revealed a massive alteration of alter-
native splicing. Our analysis identified defective exon-skipping
and intron-retention events in mutant cells, while other modal-
ities of splicing, including alternative exons and 50 or 30 acceptor(E) Representative Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl immunopanned OP
number of phophos-H3+/OLIG2+ cells in PDGF + FGF medium. White arrowhea
(F) Methylation of individual CpGs assessed by MassARRAY EpiTYPER of Meis2
including hypermethylated DMRs observed in differentiating OLs (blue rectangle
levels of indicated CpGs is shown for control (white) and mutant (gray) sorted OP
(G) Real-time qPCR analysis of transcript levels of the indicated genes in P2 and P
(white).
(H) Representative P9 spinal cord sections of Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dn
H2AX (green), with relative quantification.
(I) Representative Olig1+/+;Dnmt1fl/fl and Olig1cre/+;Dnmt1fl/fl immunopanned OP
cation in proliferating OPCs.
Scale bars, 25 mm. Data indicate mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.00sites were not affected. It has been previously reported that dif-
ferential methylation of CpGs in specific genomic areas results in
defective splicing (Gelfman et al., 2013; Hnilicova´ and Stanek,
2011; Iannone and Valca´rcel, 2013), and our study provides an
in vivo validation, in the CNS, for this proposed model. We vali-
dated the co-occurrence of differential DNA methylation and
altered retained-intron splicing in selected genes, supporting
the concept that DNA methylation is tightly linked to this form
of splicing events, and its absence results in a wide rearrange-
ment of RNA-splicing events, which, in turn, may cause aberrant
protein folding, possibly leading to the activation of an ER stress
response.
We conclude that the role of DNMT1 in OL-lineage cells is
more complex than originally anticipated and encompasses
the regulation of the proliferative state of OPC, as well as a tight
coordination between alternative splicing and protein synthesis
in the generation of myelinating OLs.
EXPERIMENTAL PROCEDURES
Animals
All experiments were conducted according to the Icahn School of Medicine at
Mount Sinai institutional animal care and use committee (IACUC)-approved
protocols. Dnmt1fl/fl (Fan et al., 2001; Jackson-Grusby et al., 2001) and
Dnmt3afl/fl (Kaneda et al., 2004) mice on a C57BL/6 background were crossed
withOlig1-cre (Jackson Laboratory), Cnp-cremice (Lappe-Siefke et al., 2003),
or Rosa26-loxP-STOP-loxP-TdTomato mice (Jackson Laboratory).
Cell Sorting
OPCs were isolated from P2 Pdgfra-GFP, P5 Olig1cre/+;Dnmt1fl/fl;Pdgfra-GFP
orOlig1+/+;Dnmt1fl/fl;Pdgfra-GFP brains (Klinghoffer et al., 2002) and OLs from
P18 Plp1-GFP brains (Spassky et al., 1998) using FACS as described previ-
ously (Moyon et al., 2015).
DNA Methylation Analysis
ERRBS libraries were prepared from 50 ng input DNA per biological replicate
following a modified (Akalin et al., 2012) protocol (Gu et al., 2011) and
sequenced using the Illumina HiSeq 2000 instrument. DMRs were selected
at a q value <0.05 and with a minimum mean difference of 10% per region.
DMRs were independently validated using MassARRAY EpiTYPER assays
(Sequenom), as previously described (Huynh et al., 2014). Genomic DNA
was sodium bisulfite treated using an EpiTect Bisulfite Kit (QIAGEN). See de-
tails and primers in the Supplemental Information.
Gene Expression Analysis
Approximately 250 ng of total RNA per sample was used for library construc-
tion with the TruSeq RNA Sample Prep Kit (Illumina) and sequenced using
the Illumina HiSeq 2000 and the Illumina HiSeq 2500 instruments according
to the manufacturer’s instructions for 50-bp (OPC-OL) or 100-bp (Dnmt1cKO)
paired-end read runs. High-quality reads were aligned to the mouse referenceCs, stained for OLIG2 (red) and phospho-H3 (green), and quantification of the
ds indicate double-positive cells.
and Cdc6 revealed hypomethylation. In blue is the complete gene structure,
s). Dotted lines identify the zoomed region containing the DMRs. Methylation
Cs.
16 spinal cord ofOlig1cre/+;Dnmt1fl/flmice (gray) relative to the levels in controls
mt1fl/flmice, stained for OLIG2 (red) and the genotoxic stress marker phospho-
Cs, stained for OLIG2 (red) and phospho-H2AX (green), and relative quantifi-
5 (ANOVA and Student’s t test).
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Figure 7. Ablation of Dnmt1 in OPCs Results in Aberrant Alternative Splicing Events and ER Stress
(A) Histogram and pie chart showing, respectively, number and proportion of alternative splicing events during normal OL development (classified in five
categories).
(B) Histogram and pie chart showing, respectively, number and proportion of alternative splicing events in mutant OPCs compared to controls.
(C) GO of genes alternatively spliced in mutant Olig1cre/+;Dnmt1fl/fl OPCs compared to Olig1+/+;Dnmt1fl/fl OPCs.
(D) Validation of retained-intron splicing of Mcm7 in Olig1cre/+;Dnmt1fl/fl OPCs by PCR.
(E) Methylation differences in individual CpGs between control (white) and mutant (gray) DNA isolated from OPC and assessed by MassARRAY EpiTYPER.
(F) Ultrastructural analysis identifies a dilated ER with inclusions (red arrows) in Olig1cre/+;Dnmt1fl/fl mice, compared to Olig1+/+;Dnmt1fl/fl controls (blue arrows).
(G) Real-time qPCR analysis of genes involved in ER stress response, including the ATF6, PERK, and IRE1 pathways, analyzed in P2, P9, and P16 spinal cord of
controls (Olig1+/+;Dnmt1fl/fl) and mutants (Olig1cre/+;Dnmt1fl/fl).
(H) Real-time qPCR analysis of ER stress response target genes assessed in P9 spinal cord of Cnp+/+;Dnmt1fl/fl and Cnpcre/+;Dnmt1fl/fl mice.
Data indicate mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.005 (ANOVA).
See also Figure S5.genome (mm10), RefSeq exons, splicing junctions, and contamination data-
bases (ribosome and mitochondria sequences) using the Burrows-Wheeler
Aligner (BWA) algorithm. The read count for each RefSeq transcript was ex-
tracted using uniquely aligned reads to exon and splice-junction regions.
The raw read counts were input into DESeq2 v1.2.5 (Anders and Huber,
2010) to normalize the signal for each transcript and to ascertain differential
gene expression with associated q values. Differentially expressed genes
were selected at a p value <0.05 and q value <0.01 with a fold change >2
for the OPC-OL comparison only. To identify enriched gene functions, we
computed hypergeometric p values for over-representation of each biological758 Cell Reports 15, 748–760, April 26, 2016process GO category using GOrilla (Eden et al., 2009). For genome-wide anno-
tation, org.Mm.eg.db was used in the GOstats R package (Falcon and Gentle-
man, 2007).
To identify alternative splicing, we used a published Bayesian statistical
framework on RNA-seq data from either Pdgfra-GFP and Plp1-GFP sorted
cells or Olig1cre/+;Dnmt1fl/fl;Pdgfra-GFP and Olig1+/+;Dnmt1fl/fl;Pdgfra-GFP
sorted cells (Shen et al., 2012). MATS can automatically detect and analyze
alternative splicing events corresponding to all major types of alternative
splicing patterns, including the following: skipped exon (SE), alternative 50
splicing site (A5SS), alternative 30 splicing site (A3SS), mutually exclusive
exon (MXE), and retained intron (RI). Spliced events between two conditions
were defined by a p value <0.05. Additional details are given in the Supple-
mental Information.
Electron Microscopy and Immunohistochemistry
For electron microscopy, mice were deeply anesthetized and transcar-
dially perfused with 0.9% NaCl, followed by 0.1 M Millonig’s solution con-
taining 4% paraformaldehyde and 5% glutaraldehyde (pH 7.3), followed
by 2 weeks of post-fixation in the same fixative solution at 4C, as previ-
ously described (He et al., 2007). For immunohistochemistry, animals
were perfused with 4% paraformaldehyde and post-fixed overnight in
the same solution at 4C. Tissue samples were then transferred to 70%
ethanol, sequentially dehydrated, and embedded in paraffin. Immunohisto-
chemistry was performed in 4- to 10-mm sections. All images were acquired
using a Zeiss Observer A1 fluorescent microscope or a Zeiss LSM780 up-
right confocal microscope. Quantification was carried out using ImageJ on
two to three sections per mouse and three to four mice for each age and
genotype.
Primary OPC Cultures
Mouse OPCs were isolated from P7 mice as described previously (Cahoy
et al., 2008), plated in 24-well dishes and kept proliferating in platelet-derived
growth factor (PDGF)-AA (10 ng/ml) and basic fibroblast growth factor (bFGF)
(20 ng/ml) or differentiated with T3 hormone (45 nM).
Rat primary glial cells were generated from 2- to 3-day-old Sprague-Dawley
rats (Harlan UK), according to published procedures.
Statistical Methods
A minimum of three replicates per group was used for each experiment.
Unpaired Student’s t test was used for cell counts and transcript levels for
every two datasets following a normal distribution. A two-way ANOVA was
used to compare three or more sets of data, including cell counts and
MassARRAY data. For all graphs, error bars indicate mean ± SEM.
ACCESSION NUMBERS
The accession number for sequencing data reported in this paper is GEO:
GSE66047.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, five tables, and one movie and can be found with this article online
at http://dx.doi.org/10.1016/j.celrep.2016.03.060.
AUTHOR CONTRIBUTIONS
S.M. and J.L.H. generated and characterized the conditional knockout mice,
performed the RT-qPCR, and analyzed RNA-seq and ERBSS data; S.M.,
R.L., and D.D. performed the lineage immunohistochemistry; S.M. alone per-
formed FACS, EpiTYPER MassARRAY, and immunocytochemistry; J.L.D.
performed the EM experiments; F.Z. performed the alternative splicing anal-
ysis; G.F. provided the floxmice; D.M. performed 5-mC reactivity experiments;
S.M., J.L.H., D.M., S.Y., C.L., R.J.M.F., G.R.J., B.E., J.Z., M.W., and P.C.
analyzed the data and provided comments; S.M. and P.C. wrote and revised
the manuscript.
ACKNOWLEDGMENTS
Thanks to A. Alonso, Y. Li, X. Zhang, Y. Xin, and the Flow Cytometry Core
CyPS (Pitie-Salpetriere Hospital, Paris) for experimental support. Thanks to
Drs. A. Sharp, C. Watson, J. Feng, and L. Wrabetz for insightful discussions
and Dr. J. Svaren for comments on the manuscript. This work was supported
by NIH-NINDS grants R37NS042925 and NS-R0152738 (P.C.) and
F31NS077504 (J.L.H.), the UK Multiple Sclerosis Society (R.J.M.F.), and
NIH-NIMH grant R01MH090948 (J.Z.).Received: March 26, 2015
Revised: February 8, 2016
Accepted: March 15, 2016
Published: April 14, 2016
REFERENCES
Akalin, A., Garrett-Bakelman, F.E., Kormaksson, M., Busuttil, J., Zhang, L.,
Khrebtukova, I., Milne, T.A., Huang, Y., Biswas, D., Hess, J.L., et al. (2012).
Base-pair resolution DNA methylation sequencing reveals profoundly diver-
gent epigenetic landscapes in acute myeloid leukemia. PLoS Genet. 8,
e1002781.
Albino, A.P., Jorgensen, E.D., Rainey, P., Gillman, G., Clark, T.J., Gietl, D.,
Zhao, H., Traganos, F., andDarzynkiewicz, Z. (2009). gammaH2AX: A potential
DNA damage response biomarker for assessing toxicological risk of tobacco
products. Mutat. Res. 678, 43–52.
Altaf, M., Saksouk, N., and Co^te´, J. (2007). Histone modifications in response
to DNA damage. Mutat. Res. 618, 81–90.
Anders, S., and Huber,W. (2010). Differential expression analysis for sequence
count data. Genome Biol. 11, R106.
Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopher-
son, K.S., Xing, Y., Lubischer, J.L., Krieg, P.A., Krupenko, S.A., et al. (2008).
A transcriptome database for astrocytes, neurons, and oligodendrocytes:
a new resource for understanding brain development and function.
J. Neurosci. 28, 264–278.
Eden, E., Navon, R., Steinfeld, I., Lipson, D., and Yakhini, Z. (2009). GOrilla: a
tool for discovery and visualization of enriched GO terms in ranked gene lists.
BMC Bioinformatics 10, 48.
Falcon, S., and Gentleman, R. (2007). Using GOstats to test gene lists for GO
term association. Bioinformatics 23, 257–258.
Fan, G., Beard, C., Chen, R.Z., Csankovszki, G., Sun, Y., Siniaia, M., Biniszkie-
wicz, D., Bates, B., Lee, P.P., Kuhn, R., et al. (2001). DNA hypomethylation
perturbs the function and survival of CNS neurons in postnatal animals.
J. Neurosci. 21, 788–797.
Fan, G., Martinowich, K., Chin, M.H., He, F., Fouse, S.D., Hutnick, L., Hattori,
D., Ge, W., Shen, Y., Wu, H., et al. (2005). DNA methylation controls the timing
of astrogliogenesis through regulation of JAK-STAT signaling. Development
132, 3345–3356.
Gelfman, S., Cohen, N., Yearim, A., and Ast, G. (2013). DNA-methylation effect
on cotranscriptional splicing is dependent on GC architecture of the exon-
intron structure. Genome Res. 23, 789–799.
Gu, H., Smith, Z.D., Bock, C., Boyle, P., Gnirke, A., and Meissner, A. (2011).
Preparation of reduced representation bisulfite sequencing libraries for
genome-scale DNA methylation profiling. Nat. Protoc. 6, 468–481.
He, F., Ge, W., Martinowich, K., Becker-Catania, S., Coskun, V., Zhu, W., Wu,
H., Castro, D., Guillemot, F., Fan, G., et al. (2005). A positive autoregulatory
loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neuro-
sci. 8, 616–625.
He, Y., Dupree, J.,Wang, J., Sandoval, J., Li, J., Liu, H., Shi, Y., Nave, K.A., and
Casaccia-Bonnefil, P. (2007). The transcription factor Yin Yang 1 is essential
for oligodendrocyte progenitor differentiation. Neuron 55, 217–230.
Hetz, C., Chevet, E., and Harding, H.P. (2013). Targeting the unfolded protein
response in disease. Nat. Rev. Drug Discov. 12, 703–719.
Hnilicova´, J., and Stanek, D. (2011). Where splicing joins chromatin. Nucleus 2,
182–188.
Hutnick, L.K., Golshani, P., Namihira, M., Xue, Z., Matynia, A., Yang, X.W.,
Silva, A.J., Schweizer, F.E., and Fan, G. (2009). DNA hypomethylation
restricted to the murine forebrain induces cortical degeneration and impairs
postnatal neuronal maturation. Hum. Mol. Genet. 18, 2875–2888.
Huynh, J.L., Garg, P., Thin, T.H., Yoo, S., Dutta, R., Trapp, B.D., Haroutunian,
V., Zhu, J., Donovan, M.J., Sharp, A.J., and Casaccia, P. (2014). Epigenome-
wide differences in pathology-free regions of multiple sclerosis-affected
brains. Nat. Neurosci. 17, 121–130.Cell Reports 15, 748–760, April 26, 2016 759
Iannone, C., and Valca´rcel, J. (2013). Chromatin’s thread to alternative splicing
regulation. Chromosoma 122, 465–474.
Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D.,
Csankovszki, G., Dausman, J., Lee, P., Wilson, C., Lander, E., and Jaenisch,
R. (2001). Loss of genomic methylation causes p53-dependent apoptosis
and epigenetic deregulation. Nat. Genet. 27, 31–39.
Jacob, V., Chernyavskaya, Y., Chen, X., Tan, P.S., Kent, B., Hoshida, Y., and
Sadler, K.C. (2015). DNA hypomethylation induces a DNA replication-associ-
ated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafish
embryos. Development 142, 510–521.
Kaneda, M., Okano, M., Hata, K., Sado, T., Tsujimoto, N., Li, E., and Sasaki, H.
(2004). Essential role for de novo DNA methyltransferase Dnmt3a in paternal
and maternal imprinting. Nature 429, 900–903.
Kessler, N.J., Van Baak, T.E., Baker, M.S., Laritsky, E., Coarfa, C., and Water-
land, R.A. (2016). CpG methylation differences between neurons and glia are
highly conserved from mouse to human. Hum. Mol. Genet. 25, 223–232.
Kevelam, S.H., Taube, J.R., van Spaendonk, R.M.L., Bertini, E., Sperle, K.,
Tarnopolsky, M., Tonduti, D., Valente, E.M., Travaglini, L., Sistermans, E.A.,
et al. (2015). Altered PLP1 splicing causes hypomyelination of early myelinat-
ing structures. Ann. Clin. Transl. Neurol. 2, 648–661.
Klinghoffer, R.A., Hamilton, T.G., Hoch, R., and Soriano, P. (2002). An allelic
series at the PDGFalphaR locus indicates unequal contributions of distinct
signaling pathways during development. Dev. Cell 2, 103–113.
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P.E.,
Griffiths, I.R., and Nave, K.A. (2003). Disruption of Cnp1 uncouples oligoden-
droglial functions in axonal support and myelination. Nat. Genet. 33, 366–374.
Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, Tv., and Passos, J.F.
(2010). Quantitative assessment of markers for cell senescence. Exp. Geron-
tol. 45, 772–778.
Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA
methyltransferase gene results in embryonic lethality. Cell 69, 915–926.
Lister, R.,Mukamel, E.A., Nery, J.R., Urich, M., Puddifoot, C.A., Johnson, N.D.,
Lucero, J., Huang, Y., Dwork, A.J., Schultz, M.D., et al. (2013). Global epige-
nomic reconfiguration during mammalian brain development. Science 341,
1237905.
Liu, J., Magri, L., Zhang, F., Marsh, N.O., Albrecht, S., Huynh, J.L., Kaur, J.,
Kuhlmann, T., Zhang, W., Slesinger, P.A., and Casaccia, P. (2015). Chromatin
landscape defined by repressive histone methylation during oligodendrocyte
differentiation. J. Neurosci. 35, 352–365.
Magri, L., Swiss, V.A., Jablonska, B., Lei, L., Pedre, X., Walsh, M., Zhang, W.,
Gallo, V., Canoll, P., and Casaccia, P. (2014). E2F1 coregulates cell cycle
genes and chromatin components during the transition of oligodendrocyte
progenitors from proliferation to differentiation. J. Neurosci. 34, 1481–1493.
Me´ndez-Acun˜a, L., Di Tomaso, M.V., Palitti, F., andMartı´nez-Lo´pez,W. (2010).
Histone post-translational modifications in DNA damage response. Cytoge-
net. Genome Res. 128, 28–36.
Milutinovic, S., Zhuang, Q., Niveleau, A., and Szyf, M. (2003). Epigenomic
stress response. Knockdown of DNA methyltransferase 1 triggers an intra-
S-phase arrest of DNA replication and induction of stress response genes.
J. Biol. Chem. 278, 14985–14995.
Moyon, S., Dubessy, A.L., Aigrot, M.S., Trotter, M., Huang, J.K., Dauphinot, L.,
Potier, M.C., Kerninon, C., Melik Parsadaniantz, S., Franklin, R.J.M., and Lu-
betzki, C. (2015). Demyelination causes adult CNS progenitors to revert to
an immature state and express immune cues that support their migration.
J. Neurosci. 35, 4–20.
Nave, K.A., Lai, C., Bloom, F.E., and Milner, R.J. (1987). Splice site selection in
the proteolipid protein (PLP) gene transcript and primary structure of the
DM-20 protein of central nervous system myelin. Proc. Natl. Acad. Sci. USA
84, 5665–5669.
Ono, T., Uehara, Y., Kurishita, A., Tawa, R., and Sakurai, H. (1993). Biological
significance of DNA methylation in the ageing process. Age Ageing 22,
S34–S43.760 Cell Reports 15, 748–760, April 26, 2016Oslowski, C.M., and Urano, F. (2011). Measuring ER stress and the unfolded
protein response using mammalian tissue culture system. Methods Enzymol.
490, 71–92.
Probst, A.V., Dunleavy, E., and Almouzni, G. (2009). Epigenetic inheritance
during the cell cycle. Nat. Rev. Mol. Cell Biol. 10, 192–206.
Ronzoni, R., Anelli, T., Brunati, M., Cortini, M., Fagioli, C., and Sitia, R. (2010).
Pathogenesis of ER storage disorders: modulating Russell body biogenesis by
altering proximal and distal quality control. Traffic 11, 947–957.
Rossetto, D., Avvakumov, N., and Co^te´, J. (2012). Histone phosphorylation:
a chromatin modification involved in diverse nuclear events. Epigenetics 7,
1098–1108.
Sen, G.L., Reuter, J.A., Webster, D.E., Zhu, L., and Khavari, P.A. (2010).
DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature
463, 563–567.
Shen, S., Park, J.W., Huang, J., Dittmar, K.A., Lu, Z.X., Zhou, Q., Carstens,
R.P., and Xing, Y. (2012). MATS: a Bayesian framework for flexible detection
of differential alternative splicing from RNA-Seq data. Nucleic Acids Res. 40,
e61.
Sher, F., Ro¨ssler, R., Brouwer, N., Balasubramaniyan, V., Boddeke, E., and
Copray, S. (2008). Differentiation of neural stem cells into oligodendrocytes:
involvement of the polycomb group protein Ezh2. Stem Cells 26, 2875–2883.
Sher, F., Boddeke, E., Olah, M., and Copray, S. (2012). Dynamic changes in
Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal
and differentiation towards oligodendrocytes. PLoS ONE 7, e40399.
Smith, Z.D., and Meissner, A. (2013). DNA methylation: roles in mammalian
development. Nat. Rev. Genet. 14, 204–220.
Spassky, N., Goujet-Zalc, C., Parmantier, E., Olivier, C., Martinez, S., Ivanova,
A., Ikenaka, K., Macklin, W., Cerruti, I., Zalc, B., and Thomas, J.L. (1998). Mul-
tiple restricted origin of oligodendrocytes. J. Neurosci. 18, 8331–8343.
Takizawa, T., Nakashima, K., Namihira, M., Ochiai, W., Uemura, A., Yanagi-
sawa, M., Fujita, N., Nakao, M., and Taga, T. (2001). DNA methylation is a
critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain.
Dev. Cell 1, 749–758.
Tawa, R., Ono, T., Kurishita, A., Okada, S., and Hirose, S. (1990). Changes of
DNA methylation level during pre- and postnatal periods in mice. Differentia-
tion 45, 44–48.
Unterberger, A., Andrews, S.D., Weaver, I.C., and Szyf, M. (2006). DNA meth-
yltransferase 1 knockdown activates a replication stress checkpoint. Mol. Cell.
Biol. 26, 7575–7586.
Valetti, C., Grossi, C.E., Milstein, C., and Sitia, R. (1991). Russell bodies: a gen-
eral response of secretory cells to synthesis of amutant immunoglobulin which
can neither exit from, nor be degraded in, the endoplasmic reticulum. J. Cell
Biol. 115, 983–994.
Varela-Rey, M., Iruarrizaga-Lejarreta, M., Lozano, J.J., Aransay, A.M., Fernan-
dez, A.F., Lavin, J.L., Mo´sen-Ansorena, D., Berdasco, M., Turmaine, M., Luka,
Z., et al. (2014). S-adenosylmethionine levels regulate the schwann cell DNA
methylome. Neuron 81, 1024–1039.
Yearim, A., Gelfman, S., Shayevitch, R., Melcer, S., Glaich, O., Mallm, J.-P.,
Nissim-Rafinia, M., Cohen, A.-H.S., Rippe, K., Meshorer, E., and Ast, G.
(2015). HP1 is involved in regulating the global impact of DNA methylation
on alternative splicing. Cell Rep. 10, 1122–1134.
Yura, K., Shionyu, M., Hagino, K., Hijikata, A., Hirashima, Y., Nakahara, T.,
Eguchi, T., Shinoda, K., Yamaguchi, A., Takahashi, K., et al. (2006). Alternative
splicing in human transcriptome: functional and structural influence on pro-
teins. Gene 380, 63–71.
Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O’Keeffe, S.,
Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014). An
RNA-sequencing transcriptome and splicing database of glia, neurons, and
vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947.
Zhou, Q., and Anderson, D.J. (2002). The bHLH transcription factors OLIG2
and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61–73.
